Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

67.19
Delayed Data
As of 4:00pm ET
 -0.19 / -0.28%
Today’s Change
64.18
Today|||52-Week Range
87.67
-20.26%
Year-to-Date
5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices
4:55pm / Zacks.com - Paid Partner Content
Anavex Life Sciences Corp. in 3 Charts
Dec 06 / MotleyFool.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. Eli Lilly
Dec 07 / MotleyFool.com - Paid Partner Content
Top Research Reports for Amazon, Ford & Dow Chemical
Dec 05 / Zacks.com - Paid Partner Content
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Dec 07 / MotleyFool.com - Paid Partner Content
Prevention of Alzheimer's is the way forward
Dec 04 / FT.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Amazon, Dow Chemical, Ford, Eli Lilly and Eni
Dec 06 / Zacks.com - Paid Partner Content
Why Eli Lilly Shares Lost 8% in November
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close67.38
Today’s open67.05
Day’s range66.39 - 67.27
Volume4,811,370
Average volume (3 months)4,751,597
Market cap$74.4B
Dividend yield3.04%
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+2.71%
Earnings growth (next 5 years)+10.90%
Revenue growth (last year)+1.75%
P/E ratio29.2
Price/Sales4.50
Price/Book5.11

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-1.26-0.66%
NVONovo Nordisk-0.23-0.65%
AZNAstraZeneca+0.42+1.62%
CELGCelgene+0.40+0.36%
Data as of 4:03pm ET, 12/08/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.97
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs